Glipzone MV 1mg/500mg/0.2mg Tablet SR
Marketer
Gonan Pharma
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Glipzone MV 1mg/500mg/0.2mg Tablet SR
Diabetol Plus 1mg/500mg/0.2mg Extended-Release Tablets are classified as antidiabetic medications. This combination therapy is indicated for adult patients with type 2 diabetes mellitus to manage blood glucose levels. Diabetol Plus should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage will be determined by your physician and may be adjusted based on your blood glucose response. Continued use is crucial, even with well-controlled blood sugar, as discontinuation without medical guidance can lead to elevated glucose, increasing the risk of complications such as nephropathy, retinopathy, neuropathy, and peripheral vascular disease. Remember, this medication is a component of a comprehensive diabetes management plan that includes diet, exercise, and weight management as advised by your doctor. Lifestyle modifications significantly contribute to diabetes control. The most frequent adverse event associated with Diabetol Plus is hypoglycemia (low blood sugar). Learn to recognize hypoglycemic symptoms (e.g., sweating, lightheadedness, headache, tremor) and implement appropriate countermeasures. Regular meals and readily available fast-acting glucose sources (e.g., sugary snacks, fruit juice) are essential. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional side effects may include altered taste perception, nausea, diarrhea, abdominal discomfort, cephalalgia, edema, visual disturbances, fractures, and upper respiratory infections. Weight gain is a possibility. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of cardiovascular disease should inform their physician before initiating treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring and periodic blood tests (complete blood count and liver function tests) are recommended as directed by your healthcare provider.
Primary Ingredients of Glipzone MV 1mg/500mg/0.2mg Tablet SR
There is no text provided to rephrase.
Uses of Glipzone MV 1mg/500mg/0.2mg Tablet SR
Managing type 2 diabetes
Major Benefits of Glipzone MV 1mg/500mg/0.2mg Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. The Glipzone MV 1mg/500mg/0.2mg Tablet SR should be swallowed whole; do not chew, crush, or break it. Administer this medication on an empty stomach.
Common Side effects of Glipzone MV 1mg/500mg/0.2mg Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Glipzone MV 1mg/500mg/0.2mg Tablet SR:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glipzone MV 1mg/500mg/0.2mg Extended-Release Tablets should be consumed on an empty stomach.
How Glipzone MV 1mg/500mg/0.2mg Tablet SR works:
Glipzone MV extended-release tablets (1mg/500mg/0.2mg) contain a triple-drug formulation for diabetes management.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glipzone MV 1mg/500mg/0.2mg SR tablets with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Glipzone MV 1mg/500mg/0.2mg Extended-Release tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Medical advice is recommended.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Glipzone MV tablet (1mg/500mg/0.2mg) is likely unsafe for breastfeeding mothers. Available human data indicate potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
The use of Glipzone MV 1mg/500mg/0.2mg SR tablets is likely unsafe for individuals with kidney impairment and should be forgone. Medical advice is recommended. Furthermore, this medication is contraindicated in patients experiencing severe kidney dysfunction.
LiverCAUTION
Individuals with liver impairment should use Glipzone MV 1mg/500mg/0.2mg SR tablets cautiously. Dosage modification of Glipzone MV 1mg/500mg/0.2mg SR tablets may be necessary. Physician consultation is advised. For those with mild to moderate liver disease, Glipzone MV 1mg/500mg/0.2mg SR tablets are typically initiated at a low dose; however, their use is contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Glipzone MV 1mg/500mg/0.2mg Tablet SR :
Should you forget a Glipzone MV 1mg/500mg/0.2mg SR Tablet dose, ingest it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glipzone MV 1mg/500mg/0.2mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently